Vaccination prevents IL-1β-mediated cognitive deficits after COVID-19

Up to 25% of SARS-CoV-2 patients exhibit post-acute cognitive sequelae. Although millions of cases of COVID-19-mediated memory dysfunction are accumulating worldwide, the underlying mechanisms and how vaccination lowers risk are unknown. Interleukin-1, a key component of innate immune defense agains...

Descripción completa

Detalles Bibliográficos
Autores principales: Vanderheiden, Abigail, Hill, Jeremy, Jiang, Xiaoping, Deppen, Ben, Bamunuarachchi, Gayan, Soudani, Nadia, Joshi, Astha, Cain, Matthew D., Boon, Adrianus C.M., Klein, Robyn S.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: American Journal Experts 2023
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10543322/
https://www.ncbi.nlm.nih.gov/pubmed/37790551
http://dx.doi.org/10.21203/rs.3.rs-3353171/v1

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10543322/
https://www.ncbi.nlm.nih.gov/pubmed/37790551
http://dx.doi.org/10.21203/rs.3.rs-3353171/v1

Ejemplares similares